We support drug discovery through translational research by providing discovery, preclinical, and translational platforms to advance oncology & immuno-oncology.Crown Bioscience is a Contract Research Organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. Our preclinical and translational services offer biotech and pharmaceutical companies the opportunity to remove the gue

Core values

- **Advancing Cancer Treatments**: Crown Bioscience is involved in several EU-funded projects aimed at advancing cancer treatments using cutting-edge technologies like organoid and _ex vivo_ patient tissue technologies. This work has the potential to identify novel biomarkers, develop companion diagnostics, and improve patient care[2][5].
- **Addressing Other Diseases**: They are also working on projects targeting Autosomal Dominant Polycystic Kidney Disease (ADPKD) and developing new therapeutic approaches, which contributes to the broader goal of improving health outcomes for patients with these conditions[2][5].
- **Quality and Safety Standards**: Crown Bioscience's commitment to achieving and maintaining high standards in quality, environmental management, and occupational health and safety (as evidenced by their ISO certifications) ensures that their research and services are conducted with the highest integrity and safety, benefiting both clients and the broader community[4].
- **Community and Social Responsibility**: The company emphasizes its responsibility to its people, customers, and the societies they serve, promoting a culture of support, development, and community engagement[1].